Osicent 80 MG (Osimertinib)


Osimertinib is a type of medication called a kinase inhibitor. It is used to treat patients with a specific type of non-small cell lung cancer (NSCLC) called metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive NSCLC. This mutation must be confirmed by an FDA-approved test. Osimertinib is prescribed for patients whose cancer has progressed despite previous treatment with EGFR tyrosine kinase inhibitors.

Whatsapp +8801922101029